title: What can proteomics tell us about platelets?
abstract: More than 130 years ago, it was recognized that platelets are key mediators of hemostasis. Nowadays, it is established that platelets participate in additional physiological processes and contribute to the genesis and progression of cardiovascular diseases. Recent data indicate that the platelet proteome, defined as the complete set of expressed proteins, comprises >5000 proteins and is highly similar between different healthy individuals. Owing to their anucleate nature, platelets have limited protein synthesis. By implication, in patients experiencing platelet disorders, platelet (dys)function is almost completely attributable to alterations in protein expression and dynamic differences in post-translational modifications. Modern platelet proteomics approaches can reveal (1) quantitative changes in the abundance of thousands of proteins, (2) post-translational modifications, (3) protein-protein interactions, and (4) protein localization, while requiring only small blood donations in the range of a few milliliters. Consequently, platelet proteomics will represent an invaluable tool for characterizing the fundamental processes that affect platelet homeostasis and thus determine the roles of platelets in health and disease. In this article we provide a critical overview on the achievements, the current possibilities, and the future perspectives of platelet proteomics to study patients experiencing cardiovascular, inflammatory, and bleeding disorders.
authors.affiliation: From the Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Dortmund, Germany (J.M.B., A.S., R.P.Z); Institut für Klinische Biochemie und Pathobiochemie, Universitätsklinikum Würzburg, Würzburg, Germany (S.G.); Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, Russia (S.G.); Centre for Cardiovascular Sciences, Institute for Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom (S.P.W.); Center for Thrombosis and Hemostasis, Universitätsklinikum der Johannes Gutenberg-Universität Mainz, Mainz, Germany (K.J., U.W.); Medizinisches Proteom Center, Ruhr Universität Bochum, Bochum, Germany (A.S.); Department of Chemistry, College of Physical Sciences, University of Aberdeen, Aberdeen, Scotland, United Kingdom (A.S.); and Department of Biochemistry, CARIM, Maastricht University, Maastricht, The Netherlands (J.W.M.H.).
authors.forename: Julia M
authors.initials: JM
authors.lastname: Burkhart
authors.forename: Stepan
authors.initials: S
authors.lastname: Gambaryan
authors.forename: Stephen P
authors.initials: SP
authors.lastname: Watson
authors.forename: Kerstin
authors.initials: K
authors.lastname: Jurk
authors.forename: Ulrich
authors.initials: U
authors.lastname: Walter
authors.forename: Albert
authors.initials: A
authors.lastname: Sickmann
authors.forename: Johan W M
authors.initials: JW
authors.lastname: Heemskerk
authors.forename: René P
authors.initials: RP
authors.lastname: Zahedi
mesh_terms: D000818:Animals; D001792:Blood Platelets / Q000737:chemistry / Q000378:metabolism*; D001798:Blood Proteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D006801:Humans; D020543:Proteome / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D040901:Proteomics / Q000379:methods*; D015398:Signal Transduction; D059467:Transcriptome
chemical_list: D001798:Blood Proteins; D020543:Proteome
keywords: bleeding; blood platelets; cardiovascular diseases; hemorrhage; proteome; proteomics